Stay updated on Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.5, updating the revision indicator from v3.6.4 as part of page maintenance. This change does not affect the displayed trial details or user actions.
    Difference
    0.1%
    Check dated 2026-08-09T11:40:00.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    No additions or deletions were provided for this page. The content state is unchanged.
    Difference
    0.1%
    Check dated 2026-08-01T23:58:38.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed, replacing Revision: v3.6.3, indicating a small version update to the page without changing study details.
    Difference
    0.1%
    Check dated 2026-07-25T23:13:33.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.2 to v3.6.3, signaling a small internal release rather than a change to the study details or how a user interacts with the page.
    Difference
    0.1%
    Check dated 2026-07-04T13:28:38.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating a minor update to the page's revision history rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:55:12.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', indicating the study is not enrolling any more participants. Additional navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions/Treatment header formatting plus a revision label update (v3.6.0) were applied.
    Difference
    0.4%
    Check dated 2026-06-13T04:41:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.